Hone Health has a women’s menopause program alongside its broader longevity services. Its public treatment menu includes several hormone routes, while membership and medication are billed separately. Readers should compare the women’s program specifically rather than assume a lower-priced general membership includes HRT care.
We checked Hone’s women’s treatment page and current help-center membership information in September 2026. This is a review of published terms and clinical questions, not a personal treatment experience. We use the newer membership overview where older pages show different prices.
Which membership applies to menopause care?
Hone’s current membership overview identifies Premium as the women’s hormone-care tier. It lists $155 per month and an initial $65 laboratory charge, with medication extra. The lower-priced Basic plan should not be treated as an HRT package.
Those published figures make the initial lab plus one month of Premium $220 before prescriptions. That is arithmetic using the listed charges, not a quote for your care. Ask when recurring billing starts, what happens if medication is not appropriate and whether any further tests or services add charges.
The menu contains different kinds of medicine
The women’s menopause page lists estrogen, progesterone, vaginal treatments and testosterone options. The women’s medication index distinguishes manufactured and compounded estradiol gel entries. That distinction is important even when the active hormone sounds the same.
Request the exact finished product and pharmacy. A brand name, ingredient name or route alone may not tell you whether a product is FDA-approved. Our bioidentical versus compounded guide explains how to ask about that status without confusing it with whether the molecule is bioidentical.
Ask what each component is intended to do
A broad menu can make it tempting to think a more complicated plan must be more complete. Instead, ask the clinician to connect each prescription to a specific symptom or diagnosis, explain the expected benefit and identify when it should be reassessed. Supplements should have their own rationale and cost discussion.
If hot flashes and vaginal discomfort occur together, ask whether one treatment is expected to cover both or whether separate care is needed. The local and systemic estrogen guide gives useful background. Do not infer that all estrogen creams have the same purpose.
Testosterone requires a focused discussion
Hone lists testosterone among its women’s offerings. Access to a product does not establish that it is indicated for a particular reader. Ask why it is being considered, what evidence supports that use and how unwanted effects would be monitored. A general goal of feeling younger is not a sufficiently specific explanation.
Our testosterone for women article discusses the evidence boundaries and absence of an FDA-approved female testosterone formulation in the United States. Also verify state-specific prescribing requirements. A women’s treatment page is not a guarantee that every listed prescription is available everywhere.
Understand the laboratory plan
Hone’s program begins with laboratory testing and clinician review. Ask which results will affect your treatment decision, whether a result needs confirmation and how testing fits with your symptoms and history. A wide panel may include information beyond the reason you sought menopause care.
Confirm the laboratory schedule and any extra charges for your own membership. Public pages can describe different testing intervals across tiers or services. You should know what is required, where to complete it and how results are explained, rather than rely on a general statement about ongoing monitoring.
Compare complete costs and follow-up access
Request an itemized estimate that includes membership, every medicine and any other proposed service. If you already have pharmacy insurance, ask whether and how it can be used; do not assume it pays for the membership. Our cost guide shows a consistent way to compare the first three months.
Ask how you contact the clinician between visits, when routine review happens and who arranges an examination if virtual care is insufficient. If systemic estrogen is prescribed and you have a uterus, get a clear explanation of the progestogen plan. The progesterone guide explains why that detail matters.
Where Hone fits
Hone is a relevant comparison for readers considering a continuing hormone program with a broad medicine menu. Its service pages do not establish that a longevity-oriented program improves lifespan or that a compounded preparation outperforms approved alternatives. We did not independently validate those broader outcomes.
Compare Joi and Defy Medical for other broad hormone offerings, and MyMenopauseRx for a visit-and-pharmacy model. The decision should rest on a clear clinical rationale, product-specific information and a care plan you can understand and afford over time.
FOLLOW THE EVIDENCE
Sources & further reading
Provider pages support service and price descriptions. Medical guidance supports treatment explanations. Neither is a first-hand review of patient outcomes. Checked September 20, 2026.
- Hone Health: women’s menopause treatment menu ↗
- Hone Health: membership overview updated August 31, 2026 ↗
- Hone Health: medicines available for women ↗
- FDA: understanding the risks of compounded drugs ↗
- ACOG: compounded bioidentical menopausal hormone therapy, reaffirmed 2026 ↗
- The Menopause Society: hormone therapy ↗